Throughout my career, I have contributed to the development, scale-up, optimization, and commercialization of a wide range of biotechnology-driven ingredient platforms and manufacturing technologies spanning nutrition, sustainable food systems, immune health, fermentation, and advanced bioprocessing.
My work has focused on bridging scientific innovation with industrial execution — enabling emerging technologies to move from laboratory development into commercially scalable manufacturing systems capable of serving global markets.
These technologies span AI-derived bioactives, precision fermentation, gas fermentation, functional ingredients, clean-label preservation systems, probiotics, pharmaceutical excipients, and advanced purification platforms.
At Nuritas, I helped lead the commercialization and manufacturing scale-up of AI-discovered bioactive peptide ingredients designed to support muscle health, recovery, and sleep quality.
These ingredients represent a new generation of biotechnology-enabled nutrition systems that combine:
My work focused on developing scalable and commercially viable manufacturing platforms capable of delivering clinically validated ingredients with high quality consistency, optimized cost structures, and global manufacturing scalability.
The technologies gained international industry attention as examples of how artificial intelligence and biotechnology can accelerate innovation in human health and nutrition.
At Air Protein, I contributed to the development and scale-up of a novel gas fermentation platform utilizing carbon dioxide and hydrogen as feedstocks for sustainable protein production.
This technology represented a significant advancement in climate-focused food biotechnology by demonstrating the feasibility of producing food ingredients using non-traditional fermentation inputs with dramatically reduced environmental footprint.
The platform integrated:
The broader technology received global recognition for its potential role in reshaping sustainable protein manufacturing and future food systems.
At Kerry, I contributed to engineering and manufacturing optimization initiatives supporting Wellmune®, a globally recognized yeast beta-glucan ingredient used in food, beverage, and nutrition applications focused on immune health.
My work supported:
The technology represented an important example of clinically supported functional ingredients being adapted for broader commercial food and beverage applications through advanced process engineering and manufacturing innovation.
I also contributed to the development and commercialization of clean-label food protection systems utilizing fermentation-derived preservation technologies designed to replace traditional synthetic preservation approaches.
This work focused on maintaining product functionality while enabling cleaner ingredient declarations and more natural preservation solutions for large-scale food applications.
The technologies incorporated:
These systems were adopted within commercial food applications supporting the growing demand for clean-label and naturally derived ingredient solutions.
Over the course of my career, I have worked extensively across industrial fermentation and downstream processing systems supporting:
This work has involved:
These experiences have contributed to a broader understanding of how biotechnology manufacturing systems can be designed and optimized for reliability, scalability, sustainability, and commercial viability.
In addition to food biotechnology platforms, I have also contributed to manufacturing systems supporting ingredients used within:
Some of these ingredient systems have supported broader pharmaceutical and healthcare manufacturing supply chains, including applications connected to biologics, diagnostics, and medical nutrition technologies.
I believe the future of food and biotechnology will be shaped not only by scientific discovery, but by the ability to industrialize innovation responsibly and efficiently at global scale.
The technologies I have worked on share a common theme:
My work continues to focus on helping bridge emerging biotechnology with industrial manufacturing systems capable of delivering meaningful real-world impact across global food, nutrition, and health industries.
